Halo Labs
Philadelphia · Founded 2011
About Halo Labs
Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics. Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year. The company was founded in 2011 and headquartered in Pennsylvania, United States.
Company Facts
- Founded: 2011
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $26.8M
- Funding stage: M&A
- Last round: Series C (Jul 2022)
- Website: halolabs.com
- Phone: 650-887-4200
Industries & Categories
Analytics, Biopharma, Biotechnology, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/halo-labs-35704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.